Rapid effects of zoledronic acid in reducing bone complications in patients with bone metastases in the first 3 months of treatment

被引：0
|
作者：
Saad, F.
Chen, Y. M.
机构：
[1] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada
[2] Novartis Oncol, E Hanover, NJ USA
来源：
CANCER TREATMENT REVIEWS | 2006年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
131
引用
下载
收藏
页码：S51 / S52
页数：2
相关论文
共 50 条
  • [1] Recommendations for zoledronic acid treatment of patients with bone metastases
    Berenson, JR
    ONCOLOGIST, 2005, 10 (01): : 52 - 62
  • [2] Zoledronic acid compared with pamidronate in patients with prostate cancer and bone metastases: Effects on skeletal complications and bone markers
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 57 - 57
  • [3] Regarding "Recommendations for zoledronic acid treatment of patients with bone metastases"
    Parles, K
    ONCOLOGIST, 2005, 10 (05): : 304 - 305
  • [4] Continuing benefit of zoledronic acid in preventing skeletal complications in patients with bone metastases
    Saad, Fred
    Chen, Yin-Miao
    Gleason, Donald M.
    Chin, Joseph
    CLINICAL GENITOURINARY CANCER, 2007, 5 (06) : 390 - 396
  • [5] Low doses of zoledronic acid reduce complications of bone metastases
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (06): : 759 - +
  • [6] Denosumab and zoledronic acid treatment in patients with genitourinary cancers and bone metastases
    Costa, Luis
    Fizazi, Karim
    Saad, Fred
    Brown, Janet Elizabeth
    Von Moos, Roger
    Oudard, Stephane
    Sternberg, Cora N.
    Ganju, Vinod
    Miller, Kurt
    Wang, Huei
    Maniar, Tapan
    Braun, Ada
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases
    Leto, G
    Badalamenti, G
    Arcara, C
    Crescimanno, M
    Flandina, C
    Tumminello, FM
    Incorvaia, L
    Gebbia, N
    Fulfaro, F
    ANTICANCER RESEARCH, 2006, 26 (1A) : 23 - 26
  • [8] Zoledronic acid effective as treatment for bone complications in prostate cancer patients
    不详
    ONCOLOGY-NEW YORK, 2002, 16 (09): : 1202 - 1202
  • [9] Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer
    Van Poznak, Catherine H.
    Unger, Joseph M.
    Darke, Amy K.
    Moinpour, Carol
    Bagramian, Robert A.
    Schubert, Mark M.
    Hansen, Lisa Kathryn
    Floyd, Justin D.
    Dakhil, Shaker R.
    Lew, Danika L.
    Wade, James Lloyd, III
    Fisch, Michael J.
    Henry, N. Lynn
    Hershman, Dawn L.
    Gralow, Julie
    JAMA ONCOLOGY, 2021, 7 (02) : 246 - 254
  • [10] Zoledronic acid has long-term efficacy in reducing skeletal complications in patients with bone metastases from breast cancer
    Coleman, R.
    Rosen, L.
    Zheng, M.
    EJC SUPPLEMENTS, 2004, 2 (03): : 127 - 128
12345